Bluejay Diagnostics, Inc. (BJDX) stock
BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.70−0.05 (-6.46%)
Close on Oct 19, 2026Market cap $1.45MP/E –Yield –
Bluejay Diagnostics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Bluejay Diagnostics's free cash flow for the twelve months ending Dec 31, 2024 was -$8.13M. For fiscal 2025 it was -$6.23M. The highest annual figure on record is -$4.39M in fiscal 2021.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$6.23M | – |
| FY2024 | Dec 31, 2024 | -$8.13M | – |
| FY2023 | Dec 31, 2023 | -$9.02M | – |
| FY2022 | Dec 31, 2022 | -$8.94M | – |
| FY2021 | Dec 31, 2021 | -$4.39M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.64M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.61M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.45M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.15M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.18M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.34M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.87M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.20M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.68M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.27M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.18M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.05M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.78M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.92M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.54M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.12M | – |
See a number that looks wrong?